Gerard Ross – GIDWG

IDMP webinar – Current status and the road to implementation

2025-05-142023-05-08 by Gerard Ross

Uppsala Monitoring Centre (UMC) sees IDMP as a game-changer for pharmacovigilance. It establishes a common language and enables the effective exchange of vital medicinal product data throughout the drug development and regulatory lifecycle. By standardising data exchange, IDMP improves our ability to identify, evaluate, and manage risks associated with medicinal products. In a one-hour webinar on 14 June 2023, UMC will discuss the current status of IDMP and collaboration efforts to implement the standards.

UPDATE: Recordings of the webinar are now available:

U.S. FDA guidelines on IDMP implementation

2025-05-142023-03-31 by Gerard Ross

The U.S. Food and Drug Administration (FDA) has released a guideline for industry titled “Identification of Medicinal Products—Implementation and Use”. This document outlines the FDA’s position and progress in aligning its standards with IDMP standards.

Identification of Medicinal Products—Implementation and Use – March 2023 [PDF]

UNICOM working paper on IDMP in ICSRs

2025-05-142021-09-30 by Gerard Ross

A key aim of UNICOM is to improve the processing and analysis of individual case safety reports (ICSRs) that describe adverse drug reactions (ADRs). To achieve this, the organisation has released the working paper titled “IDMP Coding Principles and Guidance for ICSRs“.

This paper provides recommendations for practical IDMP implementation, such as PhPID generation, and for handling drug information in general, including grouping concepts and the use of name parts. These guidelines aim to improve ICSR data management and pharmacovigilance analysis.

UNICOM-Working-Paper-on-IDMP-coding-principles-and-guidance-for-ICSRs_dissemination Download